Spotting ILDs may be challenging. Symptoms such as a dry cough, shortness of breath, and unexplained weight loss may go ...

UVA researchers unveil a breakthrough in detecting interstitial lung disease, focusing on blood biomarkers for ILD to ...

Research led by Friedrich-Alexander-Universität Erlangen–Nürnberg provides evidence that teclistamab may offer therapeutic ...

UVA Health lung researchers are developing a promising approach to detecting patients at risk of interstitial lung disease ...

The oral targeted therapy sevabertinib led to tumor reduction and manageable side effects in patients with HER2-mutant ...

Interstitial lung disease was a common adverse event with 10 of the 15 FDA-approved antibody-drug conjugates, according to data from FAERS.

Technological Advancements in Diagnosis and Treatment Transforming Interstitial Lung Disease CareThe Global Interstitial Lung ...

Childhood interstitial lung disease (chILD) comprises a heterogeneous group of rare, chronic pulmonary disorders that affect the lung parenchyma. These conditions are characterised by complex ...

Patients with inflammatory bowel disease (IBD) had a significantly higher risk for developing interstitial lung disease (ILD) compared with the general population and siblings who do not have the ...

Enhertu significantly improved IDFS compared to Kadcyla, with a 53% risk reduction in invasive disease or death in high-risk, ...

Zipalertinib shows 31% intracranial response and good tolerability in CNS-involved EGFR-mutated lung cancer, data presented ...